Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Mari-Ann Wallander"'
Autor:
Annika Bardel, Mari-Ann Wallander, Thorne Wallman, Annika Rosengren, Saga Johansson, Henry Eriksson, Kurt Svärdsudd
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211532 (2019)
OBJECTIVE:To study age and sex specific prevalence of 30 symptoms in random samples from the general population and to analyze possible secular trends across time. STUDY POPULATION:The study was based on data from eight on-going Swedish cohort studie
Externí odkaz:
https://doaj.org/article/e85bf61a391c4991898064516ddd9cca
Autor:
Miranda Davies, Luis A. García-Rodríguez, Gunnar Brobert, Tania Schink, Alison Evans, Pareen Vora, Ana Ruigómez, Saad A. W. Shakir, Kiliana Suzart-Woischnik, Leif Friberg, Mari-Ann Wallander, Yanina Balabanova, Ron M. C. Herings, Montse Soriano-Gabarró, Irene D. Bezemer
Publikováno v:
Expert opinion on drug safety, 19(11), 1513-1520. Taylor and Francis Ltd.
Expert opinion on drug safety, 19(11):1513-1520
Garcia-Rodriguez, L A, Wallander, M A, Friberg, L, Ruigomez, A, Schink, T, Bezemer, I, Herings, R, Shakir, S, Evans, A, Davies, M, Suzart-Woischnik, K, Vora, P, Balabanova, Y, Soriano-Gabarro, M & Brobert, G 2020, ' Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice ', Expert opinion on drug safety, vol. 19, no. 11, pp. 1513-1520 . https://doi.org/10.1080/14740338.2020.1798928
Expert opinion on drug safety, 19(11):1513-1520
Garcia-Rodriguez, L A, Wallander, M A, Friberg, L, Ruigomez, A, Schink, T, Bezemer, I, Herings, R, Shakir, S, Evans, A, Davies, M, Suzart-Woischnik, K, Vora, P, Balabanova, Y, Soriano-Gabarro, M & Brobert, G 2020, ' Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice ', Expert opinion on drug safety, vol. 19, no. 11, pp. 1513-1520 . https://doi.org/10.1080/14740338.2020.1798928
BACKGROUND: Rivaroxaban is a highly selective factor Xa inhibitor approved for use in Europe for multiple indications. STUDY DESIGN AND METHODS: The European rivaroxaban epidemiological post-authorization safety study (PASS) program consists of seven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f22a5e9fe6348bc402a6fbff69d4d5
https://research.vumc.nl/en/publications/2678d4a2-4f81-4c20-956c-4cc23def523a
https://research.vumc.nl/en/publications/2678d4a2-4f81-4c20-956c-4cc23def523a
Autor:
Per Lundborg, Mari-Ann Wallander
Publikováno v:
Pharmacoepidemiology ISBN: 9780203743669
Pharmacoepidemiology
Pharmacoepidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1d9a7549ed3c933f478f55742f8604b
https://doi.org/10.1201/9780203743669-14
https://doi.org/10.1201/9780203743669-14
Publikováno v:
Journal of Family Planning and Reproductive Health Care. 42:247-254
Background There are limited data to show the levels of prescribing of combined oral contraceptives (COCs) and other hormonal products containing estrogen/progestogen combinations that may be outside the product licence. Aims To determine the diagnos
Autor:
Luis A. García Rodríguez, Monste Soriano-Gabarró, Mari-Ann Wallander, Elisa Martín-Merino, Susan Andersson
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 194:147-152
Objective To determine the incidence of hysterectomy and uterus-preserving procedures (UPPs) among women with uterine fibroids (UFs) and the incidence of further procedures after a UPP. Study design This was an observational study using a primary car
Publikováno v:
Journal of Neurology
Multiple sclerosis (MS) progression to mortality may not be solely determined by the underlying autoimmune process. We conducted a study in a large cohort of MS patients with the aim of describing characteristics of MS patients and identification of
Autor:
Susan Andersson, A. Filonenko, Lucía Cea Soriano, Luis A. García Rodríguez, Mari-Ann Wallander
Publikováno v:
Pharmacoepidemiology and Drug Safety. 24:52-58
PURPOSE: The purpose of this study was to determine the continuation rates of new users of long-acting reversible contraceptive (LARC) methods in the UK, using data from general practice.METHODS: W ...
Publikováno v:
Journal of Neurology
The online version of the original article can be found under doi:10.1007/s00415-014-7370-3.
Autor:
Luis A. García-Rodríguez, Lucía Cea Soriano, Susan Andersson, Mari-Ann Wallander, Gema Requena
Publikováno v:
The European Journal of Contraception & Reproductive Health Care. 19:22-28
OBJECTIVES To develop and validate algorithms to identify new users of long-acting reversible contraceptives (LARCs) in a primary care database, The Health Improvement Network (THIN). METHODS Women in THIN aged 12 to 49 years in 2005 were studied. TH
Autor:
Mari-Ann Wallander, Nuria Riera-Guardia, Crystal N. Holick, Jordi Castellsague, Brian Calingaert, Scott C. Quinlan, Susana Perez-Gutthann, Kenneth J. Rothman, Lisa J. McQuay, Catherine W. Saltus, Kiliana Suzart, Peter Wahl, James A. Kaye, Christine L. Bui
Publikováno v:
Pharmacotherapy
Study Objective To estimate the incidence and relative risk of a hospitalization or emergency visit for noninfectious liver injury in users of eight oral antimicrobials—amoxicillin, amoxicillin-clavulanic acid, clarithromycin, cefuroxime, doxycycli